Asalyxa Bio: Funding, Investors & Team (Sep 2026)
Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With applications across a wide array of disease areas and conditions, Asalyxa Bio's platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells.
Asalyxa Bio has raised $2.0M across 1 funding round on record, the most recent a Seed of $2.0M announced in Feb 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Asalyxa Bio Company Profile and Key Stats
Latest funding round on record: Feb 2021.
Asalyxa Bio Funding Rounds
Asalyxa Bio Founders and Leadership Team
No contact details are on record for this team yet.
Asalyxa Bio Funding Compared to Other Biotechnology Startups
Asalyxa Bio's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Asalyxa Bio in Biotechnology and Southfield
Companies Similar to Asalyxa Bio
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Asalyxa Bio Funding FAQs
What does Asalyxa Bio do?
Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With applications across a wide array of disease areas and conditions, Asalyxa Bio's platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells.
How much funding has Asalyxa Bio raised?
Asalyxa Bio has raised $2.0M across 1 round on record. The most recent is a Seed of $2.0M announced in Feb 2021.
When did Asalyxa Bio last raise funding?
Asalyxa Bio's most recent funding round on record is a Seed of $2.0M, announced in Feb 2021.
Who is the CEO of Asalyxa Bio?
Marc Appel is listed as CEO at Asalyxa Bio.
Where is Asalyxa Bio headquartered?
Asalyxa Bio is based in Southfield, Michigan, United States.
How many employees does Asalyxa Bio have?
Asalyxa Bio is in the 11-50 employee band.
How does Asalyxa Bio's funding compare to other Biotechnology startups?
Asalyxa Bio's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Asalyxa Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Asalyxa Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.